Costimulatory molecules and cytotoxic T cells in chronic hepatitis C: Defence mechanisms devoted to host integrity or harmful events favouring liver injury progression? A revlew

Immunopharmacology and Immunotoxicology

Volumn 20, Issue 4, 1998, Pages 455-472

  Antonaci, Salvatore ^a,b   Schiraldi, Oronzo ^a  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^b POLICLINICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CD8 ANTIGEN; CD86 ANTIGEN; GRANZYME A; LEUKOCYTE ANTIGEN; PERFORIN; T LYMPHOCYTE RECEPTOR;

ANTIGEN EXPRESSION; CYTOTOXIC T LYMPHOCYTE; HEPATITIS C; HOST RESISTANCE; HUMAN; IMMUNOPATHOGENESIS; LIVER NECROSIS; PRIORITY JOURNAL; REVIEW;

EID: 0031753677     PISSN: 08923973     EISSN: None     Source Type: Journal    
DOI: 10.3109/08923979809031510     Document Type: Review

References (62)

1. Iwarson, S., Norkrans, G., Wejtal, R., Hepatitis C: natural history of a unique infection, Clin. Infect. Dis., 20:1361, 1995.
2. Fiore, G., Jirillo, E., Schiraldi, O., Antonaci, S., Hepatitis C virus infection. Biological and immunological features, Rec. Progr. Med., 87:301, 1996.
3. Yano, M., Yatsuhashi, H., Inoue, O., Inokuchi, K., Koga, M., Epidemiology and long-term prognosis of hepatitis C virus infection in Japan, Gut, 34:13, 1993.
4. Hiramatsu, N., Hayashi, N., Haruna, Y., Kasahara, A., Fusamoto, H., Mori, C., Fuke, I., Okayama, H., Kamada, T., Immunohistochemical detection of hepatitis C virus-infected hepatocytes in chronic liver disease with monoclonal antibodies to core, envelope and NS3 regions of the hepatitis virus genome, Hepatology, 16:306, 1992.
5. Takehara, T., Hayashi, N., Mita, E., Hagiwara, H., Ueda, K., Katayama, K., Kasahara, A., Fusamoto, H., Kamada, T., Detection of the minus strand of hepatitis C virus RNA by reverse transcription and polymerase chain reaction: implications for hepatitis C virus replication in infected tissue, Hepatology, 15:387, 1992.
6. Del Prete, G., Maggi, E., Romagnani, S., Human Th1 and Th2 cells: functional properties, mechanisms of regulation, and role in disease, Lab. Invest., 70:299, 1994.
7. Mosmann, T.R., Cherwinski, H., Bond, M.W., Giedlin, M.A., Coffman, R.L., Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins, J. Immunol., 136:2348, 1986.
8. Street, N.E., Schumacher, J.H., Fong, T.A., Bass, H., Fiorentino, D.F., Leverah, J.A., Mosmann, T.R., Heterogeneity of mouse helper T cells: evidence from bulk cultures and limiting dilution cloning for precursors of Th1 and Th2 cells, J. Immunol., 144:1629, 1990.
9. Tsai, S.L., Liaw, Y.F., Chen, M.H., Huang, C.Y., Kuo, G.C., Detection of Type 2-like T helper cells in hepatitis C virus (HCV) infection: implications for HCV chronicity, Hepatology, 25:449, 1997.
10. Tsai, S.L., Huang, S.N., T cell mechanisms in the immunopathogenesis of viral hepatitis B and C, J. Gastroenterol. Hepatol., 12 (suppl.):S227, 1997.
11. Koziel, M.J., Dudley, D., Wong, J.T., Dienstag, J., Houghton, M., Ralston, R., Walker, B.D., Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis, J. Immunol., 149:3339, 1992.
12. Koziel, M.J., Dudley, D., Afdhal, N., Choo, Q.L., Houghton, M., Ralston, R., Walker, B.D., Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV, J. Virol., 67:7522, 1993.
13. Volpes, R., Van Den Oord, J.J., Desmet, V.J., Memory T cells represent the predominant lymphocyte subset in acute and chronic liver inflammation, Hepatology, 13:826, 1991.
14. Fiore, G., Galetta, V., Piazzolla, G., Angarano, I., Jirillo, E., Schiraldi, O., Antonaci, S., CD45RA and CD45RO isoform expression on intrahepatic T lymphocytes in chronic hepatitis C, Microbios, 92:73, 1997.
15. Onji, M., Kikuchi, T., Kumon, I., Masumoto, T., Nadano, S., Kajino, K., Horiiken, N., Ohta, Y., Intrahepatic lymphocyte subpopulations and HLA class I antigen expression by hepatocytes in chronic hepatitis C, Hepatogastroenterology, 39:340, 1992.
16. Fiore, G., Angarano, I., Caccetta, L., Serrone, M., Jirillo, E., Schiraldi, O., Antonaci, S., In-situ immunophenotyping study of hepatic-infiltrating cytotoxic cells in chronic active hepatitis C, Eur. J. Gastroenterol. Hepatol., 9:491, 1997.
17. Fiore, G., Piazzolla, G., Angarano, I., Galetta, V., Caccetta, L., Jirillo, E., Schiraldi, O., Antonaci, S., Intrahepatic cytotoxic cell infiltrates in chronic hepatitis B and C: a comparative immunohistochemical study, Med. Sci. Res., 25:755, 1997.
18. Khakoo, S.I., Soni, P.N., Savage, K., Brown, D., Dhillon, A.P., Poulter, L.W., Dusheiko, G.M., Lymphocyte and macrophage phenotypes in chronic hepatitis C infection, Am. J. Pathol., 150:963, 1997.
19. Mosnier, J.F., Scoazec, J.Y., Marcellin, P., Degott, C., Benhamou, J.P., Feldmann, G., Expression of cytokine-dependent immune adhesion molecules by hepatocytes and bile duct cells in chronic hepatitis C, Gastroenterology, 107:1457, 1994.
20. Chisari, F.V., Cytotoxic T cells and viral hepatitis, J. Clin. Invest, 99:1472, 1997.
21. Wong, D.K.H., Dudley, D.D., Afdhal, N.H., Dienstag, J., Rice, C.M., Wang, L., Houghton, M., Walker, B.D., Koziel, M.J., Liver-derived CTL in hepatitis C virus infection: breadth and specificity of responses in a cohort of persons with chronic infection, J. Immunol., 160:1479, 1998.
22. Schwartz, R. H., Costimutation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin 2 production and immunotherapy, Cell, 71:1065, 1992.
23. Boussiotis, V.A., Freeman, G.J., Gribben, J.G., Nadler, L.M., The role of B7-1/B7-2:CD28/CTLA-4 pathways in the prevention of anergy, induction of productive immunity and down-regulation of the immune response, Immunol. Rev., 153:5, 1996.
24. Lenschow, D.J., Walunas, T.L., Bluestone, J.A., CD28/B7 system of T cell costimulation, Annu. Rev. Immunol., 14:233, 1996.
25. Gimmi, C.D., Freeman, G.J., Gribben, J.G., Sugita, K., Freedman, A.S., Morimoto, C., Nadler, L.M., B-cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin-2, Proc. Natl. Acad. Sci. USA, 88:6575, 1991.
26. Linsiey, P.S., Brady, W., Grosmaire, L., Aruffo, A., Damle, N.K., Ledbetter, J.A., Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin-2 accumulation, J. Exp. Med., 173:721, 1991.
27. + cell subsets, Arch. Gerontol. Geriatr, 26:55, 1997.
28. Blazar, B.R., Taylor, P.A., Linsley, P.S., Vallera, P.A., In vivo blockade of CD28/CTLA4:B7/BB1 interaction with CTLA4-lg reduces lethal murine graft-versus-host disease across the major histocompatibility complex barrier in mice, Blood, 83:3815, 1994.
29. Lenschow, D.J., Ho, S.C., Sattar, H., Rhee, L., Gray, G., Nabavi, N., Herold, K.C., Bluestone, J.A., Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse, J. Exp. Med., 181:1145, 1995.
30. Bluestone, J.A., Is CTLA-4 a master switch for peripheral T cell tolerance?, J. Immunol., 158:1989, 1997.
31. + mature thymocytes, J. Immunol., 144:1646, 1990.
32. Hathcock, K.S., Laszlo, G., Pucillo, C., Linsiey, P., Hodes, R.J., Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function, J. Exp. Med., 180:631, 1994.
33. Linsley, P.S., Greene, J.L., Brady, W., Bajorath, J., Ledbetter, J.A., Peach, R., Human B7-1 (CD80) and B7-2 bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors, Immunity, 1:793, 1994.
34. Kuchroo, V.K., Prabhu Das, M., Brown, J.A., Ranger, A.M., Zamvil, S.S., Sobel, R.A., Weiner, H.L., Nabavi, N., Glimcher, L.H., B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy, Cell, 80:707, 1995.
35. Greenfield, E.A., Howard, E., Paradis, T., Nguyen, K., Benazzo, F., McLean, P., Hollsberg, P., Davis, G., Hafler, D.A., Sharpe, A.H., Freeman, G.J., Kuchroo, V.K., B7.2 expressed by T cells does not induce CD28-mediated costimulatory activity but retains CTLA4 binding, J. Immunol., 158:2025, 1997.
36. Spengler, U., Leifeld, R., Braunschweiger, I., Dumoulin, F.L., Lechmann, M., Sauerbruch, T., Anomalous expression of costimulatory molecules B7-1, B7-2 and CD28 in primary biliary cirrhosis, J. Hepatol., 26:31, 1997.
37. Kaji, K., Tsuneyama, K., Nakanuma, Y., Harada, K., Sasaki, M., Kaneko, S., Kobayashi, K., B7-2 positive cells around interlobular bile ducts in primary biliary cirrhosis and chronic hepatitis C, J. Gastroenterol. Hepatol., 12:507, 1997.
38. Mochizuki, K., Hayashi, N., Katayama, K., Hiramitsu, N., Kanto, T., Mita, E., Tatsumi, T., Kuzushita, N., Kasahara, A., Fusamoto, H., Yokochi, T., Kamada, T., B7/BB-1 expression and hepatitis activity in liver tissues of patients with chronic hepatitis C, Hepatology, 25:713, 1997.
39. Liu, C.C., Young, L.H.Y., Young, J.D.E., Lymphocyte-mediated cytolysis and disease, N. Engl. J. Med., 335:1651, 1996.
40. Rehermann, B., Chang, K.M., McHutchison, J.G., Kokka, R., Houghton, M., Chisari, F.V., Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection, J. Clin. Invest, 98:1432, 1996.
41. Nelson, D.R., Marousis, C.G., Davis, G.L., Rice, C.M., Wong, J., Houghton, M., Lau, J.Y.N., The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C, J. Immunol., 158:1473, 1997.
42. Kerr, J.F.R., Cooksley, W.G.E., Searle, J., Halliday, J.W., Halliday, W.J., Holder, L., Roberts, I., Burnett, W., Powell, L.W., The nature of piecemeal necrosis in chronic active hepatitis, Lancet, 2:827, 1979.
43. Yonehara, S., Ishii, A., Yonehara, M., A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor, J. Exp. Med., 169:1747, 1989.
44. Hiramatsu, N., Hayashi, N., Katayama, K., Mochizuki, K., Kawanishi, Y., Kasahara, A., Fusamoto, H., Kamada, T., Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C, Hepatology, 19:1354, 1994.
45. Mita, E., Hayashi, N., Iio, S., Takehara, T., Hijioka, T., Kasahara, A., Fusamoto, H., Kamada, T., Role of Fas ligand in apoptosis induced by hepatitis C virus infection, Biochem. Biophys. Res. Commun., 204:468, 1994.
46. Okazaki, M., Hino, K., Fujii, K., Kobayashi, N., Okita, K., Hepatic Fas antigen expression before and after interferon therapy in patients with chronic hepatitis C, Dig. Dis. Sci., 41:2453, 1996.
47. Ohishi, M., Sakisaka, S., Koji, T., Nakane, P.K., Tanikawa, K., The localization of HCV and the expression of Fas antigen in the liver of HCV-related chronic liver disease, Acta Histochem. Cytochem., 28:341, 1995.
48. Weller, M., Frei, K., Groscurth, P., Krammer, P.H., Yonekawa, Y., Fontana, A., Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells: induction and modulation of sensitivity by cytokines, J. Clin. Invest., 94:954, 1994.
49. Wei, W.Z., Lindquist, R.R., Alloimmune cytolytic T lymphocyte activity: triggering and expression of killing mechanisms in cytolytic T lymphocytes, J. Immunol., 126:513, 1981.
50. Ando, K., Hiroishi, K., Kaneko, T., Moriyama, T., Muto, Y., Kayagaki, N., Yagita, H., Okumura, K., Imawari, M., Perform, Fas/Fas ligand, and TNF-α pathways as specific and bystander killing mechanisms of hepatitis C virus-specific human CTL, J. Immunol., 158:5283, 1997.
51. Hayata, T., Nakano, Y., Yoshizawa, K., Sodeyama, T., Kiyosawa, K., Effects of interferon on intrahepatic human leukocyte antigens and lymphocyte subsets in patients with chronic hepatitis B and C, Hepatology, 13:1022, 1991.
52. + CTL, J. Immunol., 159:2728, 1997.
53. Corado, J., Toro, F., Rivera, H., Bianco, N.E., Deibis, L., De Sanctis, J.B., Impairment of natural killer (NK) cytotoxic activity in hepatitis C virus (HCV) infection, Clin. Exp. Immunol., 109:451, 1997.
54. Lanier, L.L., Phillips, J.H.,. Inhibitory MHC class I receptors on NK cells and T cells, Immunol. today, 117:86, 1996.
55. Olcese, L., Lang, P., Vely, F., Cambiaggi, A., Marguet, D., Blery, M., Hippen, K.L., Biassoni, R., Moretta, A., Moretta, L., Gambier, J.C., Vivier, E., Human and mouse killer-cell inhibitory receptors recruit PTP1C and PTP1D protein tyrosine phosphatases, J. Immunol., 156:4531, 1996.
56. Piazzolla, G., Tortorella, C., Fiore, G., Serrone, M., Caccetta, L., Jirillo, E., Schiraldi, O., Antonaci, S., Immunoresponsiveness in chronic hepatitis C patients: correlation between tissue and serum findings, Immunopharmacol. Immunotoxicol., 20:000, 1998.
57. Puppo, F., Scudeletti, M., Indiveri, F., Ferrone, S., Serum HLA class I antigens: markers and modulators of an immune response?, Immunol. today, 16:124, 1995.
58. Hiroishi, K., Kita, H., Kojima, M., Okamoto, H., Moriyama, T., Kaneko, T., Ishikawa, T., Ohnishi, S., Aikawa, T., Tanaka, N., Yazaki, Y., Mitamura, K., Imawari, M., Cytotoxic T lymphocyte response and viral load in hepatitis C virus infection, Hepatology, 25:705, 1997.
59. Hayashi, T., Kishihara, Y., Yamaji, K., Furusyo, N., Yamamoto, T., Pae, Y., Etoh, Y., Ikematsu, H., Kashiwagi, S., Hepatitis C viral quasispecies and liver damage in patients with chronic hepatitis C virus infection, Hepatology, 25:697, 1997.
60. Weiner, A.J., Geysen, H.M., Christopherson, C., Hall, J.E., Mason, T.J., Saracco, G., Bonino, F., Crawford, K., Marion, C.D., Crawford, K.A., Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections, Proc. Natl. Acad. Sci. USA, 89:3468, 1992.
61. + T lymphocytes by murine monoclonal CD8 antibodies and restored specific T cell proliferation in vivo in a patient with chronic hepatitis C, J. Immunol., 159:4064, 1997.
62. Lerat, H., Berby, F., Trabaud, M.A., Vidalin, O., Major, M., Trepo, C., Inchauspe, G., Specific detection of hepatitis C virus minus strand RNA in hematopoietic cells, J. Clin. Invest, 97:845, 1996.